A detailed history of Wells Fargo & Company transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 26,170 shares of VNDA stock, worth $133,205. This represents 0.0% of its overall portfolio holdings.

Number of Shares
26,170
Previous 25,548 2.43%
Holding current value
$133,205
Previous $144,000 15.28%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$4.61 - $6.34 $2,867 - $3,943
622 Added 2.43%
26,170 $122,000
Q2 2024

Aug 13, 2024

BUY
$3.91 - $6.5 $19,866 - $33,026
5,081 Added 24.83%
25,548 $144,000
Q1 2024

May 10, 2024

BUY
$3.47 - $4.61 $9,601 - $12,755
2,767 Added 15.63%
20,467 $84,000
Q4 2023

Feb 09, 2024

BUY
$3.38 - $4.58 $10,714 - $14,518
3,170 Added 21.82%
17,700 $74,000
Q3 2023

Nov 13, 2023

SELL
$4.28 - $6.57 $204,365 - $313,710
-47,749 Reduced 76.67%
14,530 $62,000
Q2 2023

Aug 15, 2023

BUY
$5.9 - $6.95 $61,731 - $72,717
10,463 Added 20.19%
62,279 $410,000
Q1 2023

May 12, 2023

BUY
$6.18 - $7.99 $307,955 - $398,149
49,831 Added 2510.38%
51,816 $351,000
Q4 2022

Feb 13, 2023

SELL
$6.87 - $10.96 $17,580 - $28,046
-2,559 Reduced 56.32%
1,985 $14,000
Q3 2022

Nov 14, 2022

SELL
$9.44 - $11.76 $4,332 - $5,397
-459 Reduced 9.17%
4,544 $46,000
Q2 2022

Aug 12, 2022

SELL
$9.31 - $11.84 $753,225 - $957,915
-80,905 Reduced 94.18%
5,003 $54,000
Q1 2022

May 16, 2022

SELL
$10.84 - $16.55 $162,545 - $248,167
-14,995 Reduced 14.86%
85,908 $971,000
Q4 2021

Feb 14, 2022

SELL
$15.69 - $21.14 $3.3 Million - $4.44 Million
-210,030 Reduced 67.55%
100,903 $1.58 Million
Q3 2021

Nov 15, 2021

SELL
$15.35 - $21.27 $1.62 Million - $2.24 Million
-105,267 Reduced 25.29%
310,933 $5.33 Million
Q2 2021

Aug 16, 2021

BUY
$15.71 - $21.51 $4.24 Million - $5.8 Million
269,632 Added 183.96%
416,200 $8.95 Million
Q1 2021

May 13, 2021

BUY
$13.42 - $20.28 $78,533 - $118,678
5,852 Added 4.16%
146,568 $2.2 Million
Q4 2020

Feb 09, 2021

BUY
$9.77 - $13.81 $73,548 - $103,961
7,528 Added 5.65%
140,716 $1.85 Million
Q3 2020

Nov 05, 2020

SELL
$9.32 - $12.02 $84,457 - $108,925
-9,062 Reduced 6.37%
133,188 $1.29 Million
Q2 2020

Aug 13, 2020

SELL
$9.66 - $12.02 $523,948 - $651,952
-54,239 Reduced 27.6%
142,250 $1.63 Million
Q1 2020

May 14, 2020

BUY
$7.5 - $16.8 $1.47 Million - $3.3 Million
196,489 New
196,489 $2.04 Million

Others Institutions Holding VNDA

About Vanda Pharmaceuticals Inc.


  • Ticker VNDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,561,500
  • Market Cap $288M
  • Description
  • Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...
More about VNDA
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.